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ABSTRACT 
The aim of the present study is to formulate and evaluate the fluconazole microsponge by using Eudragit L 100. Microsponge wa s made because 
they provide controlled as well as target specific release of the drug. Thus study the effect of stirring rate on the formation of microsponge. 
Microsponge containing Fluconazole were prepared by quasi-emulsion solvent diffusion method at different stirring rate i.e 500, 800, 1000, 
1200 and 1500 rpm. Particle size of prepared microsponge was observed in the range of 76.2 to 32.5μm. Scanning electron microscopy 
revealed the porous, spherical nature of the microsponges. The production yield, entrapment efficiency and drug content were found to be 
78.24%, 82.76%, 81.36%. The impact of Drug: Polymer ratio and process variables i.e stirring speed and stirring time on the physical features 
of microsponges like production yield, mean particle size, entrapment efficiency were examined. It was shown that production yield, drug 
content and entrapment efficiency was found to be increase with increase in drug polymer ratio while drug: polymer ratio has reverse effect on 
particle size, as drug: polymer ratio increase, particle size decrease. As the polymer concentration increased, more amount of polymer 
surrounding the drug, thus increasing the thickness of the wall of the polymer matrix which lead to extended diffusion path and ultimately to 
lesser drug release or more sustained release. The effect of stirring rate on the morphology of microsponge. The formulation with higher drug 
to polymer ratio 1:8 (i.e F4) was chosen to investigate the effect of stirring rate on the morphology of microsponges. The dispersion of the drug 
and polymer within the aqueous phase was found to be dependent on the agitation speed. As the speed was increased the size of microsponges 
was reduced and the microsponges were found to be spherical and uniform.  
Keywords: Novel drug delivery system, Microsponges, Eudragit L 100, Fluconazole, Quasi-emulsion solvent diffusion method.  
 
Article Info: Received 01 May 2019;    Review Completed 31 May 2019;    Accepted 06 June 2019;    Available online 15 June 2019 
 Cite this article as: 
Hans H, Dua JS, Prasad DN, Monika, Sharma D,  Formulation and Evaluation of Fluconazole Microsponge using Eudragit L 
100 by Quasi Emulsion Solvent Diffusion Method, Journal of Drug Delivery and Therapeutics. 2019; 9(3-s):366-373   
http://dx.doi.org/10.22270/jddt.v9i3-s.2855              
*Address for Correspondence:  
Hans Mansi, Department of Pharmaceutics, Shivalik College of Pharmacy, Nangal, Punjab, India (Email: mansihns@gmail.com) 
 
 
INTRODUCTION  
A microsponge delivery system is a uniform, spherical, 
porous, highly cross-linked polymeric microspheres or tiny 
sponge-like spherical particles with large porous surface. 
They enhance stability, reduced side effects and modify drug 
release. It consists of micro-porous beads, typically 10-25 
microns in diameter, loaded with active agents. Besides, they 
may enhance stability, modify drug release and reduce side 
effects favourably. Like a true sponge, each microsphere 
consists of a myriad of interconnecting voids of particles 
from 5-150μm within a non-collapsible structure, with a 
large porous surface 1.  
Microsponge systems are based on microscopic, polymer- 
based microspheres that can suspend or entrap a wide 
variety of substances, and can then be incorporated into a 
formulated products such as a gel, cream, liquid or powder 2. 
Microsponge drug delivery system can confer increased 
efficacy for topically active agents with enhanced safety, 
improved aesthetic properties and extended product 
stability in an well-formed manner. Subjected over the size, 
the total pore length may range up to 10 ft and pore volume 
up to 1 ml/gm. When applied to the skin surface, the 
microsponge drug delivery system discharges its active 
ingredient on a time mode and also in respond to other 
stimuli 3. Microsponges have the capacity to adsorb or load a 
high degree of active materials into the particle or onto its 
surface. Its huge capacity for entrapment of actives up to 3 
times its weight differentiates microsponges from different 
mode of dermatological delivery systems. Recently, 
microsponge delivery system has been successively 
addressed for the controlled release of drugs onto the 
epidermis with assurance that the drug remains chiefly 
localized and does not enter the systemic circulation in 
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major amounts and resulted in a new creation of highly 
efficacious and well tolerated novel products 2.  
It is unique technology for the controlled release of topical 
agents. Fluconazole is a trizole antifungal agent used for the 
treatment of systemic and superficial fungal infection. The 
purpose of the present investigation was to formulate and 
evaluate fluconazole loaded Microsponges using Eudragit L 
100 for the controlled release of drug and study the effect of 
stirring rate on the formulation of microsponge 4.  
MATERIALS AND METHODS  
Materials: Fluconazole gift sample obtained from Haustus 
Biotech. Pvt. Ltd., Tahliwal (Una), Dibutyl phthalate was 
procured from SD fine chem. Ltd. Mumbai, Polyvinyl alcohol 
was procured from Glaxo smith kline pharmaceuticals Ltd. 
Mumbai, Dichloromethane was procured from RFCL limited 
Gujrat India, Ethanol and KBr was procured from Central 
drug house (p) Ltd. New Delhi, and distilled water.  
 
Method of Preparation of Fluconazole Microsponges  
Fluconazole Microsponges were prepared by quasi-emulsion 
solvent diffusion method. To prepare the internal phase, 
fluconazole was  dissolved  in  20  ml  of  dichloromethane:  
ethanol  (1:1) mixture  to  dissolve  both  the  drug  and  the  
polymer (Eudragit L 100)  and  to  this  add 0.5 ml dibutyl 
phthalate as a plasticizer. The external phase containing 100 
mg of PVA in water.  The  external  phase  was  placed  in  the  
vessel  with  propeller  stirrer rotating  at different rpm,  to  
this  add  slowly  internal  phase.  The system was thermally 
controlled at 25° C in a water bath. Agitations up to 30 min 
permit the formation of microsponges and continue stirring 
for 8h to get desired rigid microsponges. After 8h stop  
stirring  filter  the  rigid micro sponges  through  the  filter  
paper  (Whatmann  filter paper  0.45  µm),  washed  with  
distilled  water  and  dried  at  room  temperature 5,6. 
Fluconazole microsponges were prepared using various 
drug: polymer ratios i.e. 1:2, 1:4, 1:6, 1:8, 1:10 at different 
stirring rate of 500, 800, 1000, 1200 and 1500 rpm. The 
formula  of  various microsponge are shown in table 1.  
 
Table 1 Micro sponge Formulations of Fluconazole Microsponges 
Formulation 
Code  
Drug: 
Polymer 
ratio  
Drug 
(mg)  
Eudragit L 
100 (mg)  
Ethanol+ 
Dichloro-
methane 
(ml)  
Polyvinyl 
alcohol 
(mg)  
Distilled 
Water (ml)  
Dibutyl 
phthalate 
(ml) 
Stirring 
rate 
(RPM)  
F1 1:2 100 200 20 100 150 0.5 500 
F2 1:4 100 400 20 100 150 0.5 800 
F3 1:6 100 600 20 100 150 0.5 1000 
F4 1:8 100 800 20 100 150 0.5 1200 
F5 1:10 100 1000 20 100 150 0.5 1500 
 
Evaluation of microsponges  
Production/ percentage yield:  The dried microsponges of 
each batch are weight separately and percentage yield is 
calculated by using following equation:-  
Percentage yield 
               
                 
       
Entrapment efficiency (EE)/ Loading efficiency and 
Actual Drug Content: 100 mg of microsponges were 
accurately weighted. They were powdered and extracted 
with 100 ml of method. Further it was serially diluted with 
pH 7.4 phosphate buffer 7,8. The resulting solution was 
analysed for fluconazole drug content by measuring 
absorbance in a UV spectrophotometer at 260nm using pH 
7.4 phosphate buffer as blank. The studies were carried out 
in triplicate. The actual drug content and entrapment 
efficiency were deliberate as:  
 Actual drug content(%)=(Mact/Mms)*100 
 Entrapment efficiency(%)=Mact/Mthe)*100 
Where Mact is the actual amount of fluconazole in weighed  
quantity of microsponges, Mms is the weighed quantity of 
microsponges and Mthe is the theoretical amount of 
fluconazole in microsponges.   
Average size of microsponge  
Particle size of all the prepared batches of microsponge was 
determined using optical microscopy at 10X and 40X. The 
microsponges were placed on glass and observe under 
optical microscope. The size of 50-100 microsponges was 
measured using optical microscope. Then the particle size, 
shape and surface was calculated.  
Scanning electron microscopy  
Scanning electron microscopy is an electron optical imaging 
technology that confers photographic pictures and elemental 
knowledge. SEM is useful for characterizing the morphology 
and size of microscopic specimens with particle size as low 
as nano meter to deca meter, the sample is installed in an 
evacuated chamber and check in a controlled pattern by an 
electron beam. Interaction of the electron beam with the 
sample originate a kind of physical phenomena that when 
discover are used to form pictures and confer elemental 
information about the samples 9,10. Microsponge were fixed 
on aluminium studs and coated with gold using a sputter 
coater SC 502, under vacuum [0.1 mm Hg]. The microsponge 
were then analysed by scanning electron microscopy (SEM).  
In vitro dissolution studies: The release of fluconazole 
from microponge was investigated in pH 7.4 phosphate 
buffer as dissolution medium (900ml) using USP type I 
apparatus. A sample of microsponge equivalent to 100mg of 
fluconazole was taken in the basket. A speed of 52 rpm and 
temperature of 37± 0.5 °c was maintained throughout the 
experiment. At fixed intervals, aliquots (5ml) were withdraw 
and replaced with fresh dissolution media. The 
concentration of drug released at different time intervals 
was then determined by measuring the absorbance using 
Double beam UV spectrophotometer at 260 nm against 
blank. The studies were carried out in triplicate 11,12.   
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Kinetic Modelling  
Data obtained from in-vitro release studied was evaluated to 
check the goodness of fit to various kinetics equations for 
quantifying the phenomena controlling the release from 
microspheres. The kinetic models were used like zero order, 
first order, and Higuchi and Korsmeyer - peppas model. The 
goodness of fit was evaluated using the correlation 
coefficient value (R2) 13,14. 
The results of in-vitro release profile obtained for all the 
formulations were plotted in kinetic models as follows, 
1. cumulative of drug released versus time (zero order 
kinetic models). 
2. Log cumulative percent drug remaining to be absorbed 
versus time (First order model) 
3. Cumulative amount of drug release versus square root of 
time (Higuchi model) 
4. Log of cumulative drug release versus log time 
(Korsmeyer – peppas model)  
Zero Order Kinetics: It gives the system in which the drug 
release rate is independent on its concentration 15. 
Qt  = Qo+Ko t 
Where 
Qt=Amount of drug dissolved in time t. 
Qos= Initial amount of drug in the solution, 
Ko= zero order release constant. 
If the zero order drug release kinetic is obeyed, then a plot of 
Qt versus t will give a 
Straight line with a slope of Ko and an intercept at zero. 
First Order Kinetics 
It gives the drug release from the systems in which the 
release rate is dependent on concentration 17. 
Log Qt  =log Qo + kt/2.303 
Where 
Qt = released amount of drug in time t. 
Qo = initial amount of  the drug containing solution 
k= first order release constant 
If the first order drug release kinetic is followed, then a plot 
of log ( Qo - Qt) versus t will be 
Straight line. 
With a slope of kt/2.303 and an intercept at t=0 of log Qo 
Higuchi Model 
It explains the fraction of drug release from a matrix is 
proportional to square root of time. 
Mt/M∞=kt ½  
Where  
Mt And M∞ = cumulative amounts of drug release at time t and 
infinite time, 
And k = Higuchi dissolution constant reflection formulation 
characteristics. If the Higuchi model of drug release (i.e. 
Fickian diffusion) is obeyed, then a plot of Mt / M∞ versus 
t1/2 will be straight line with slope of k 16. 
 
Korsemeyer- Peppas model (Power Law) 
The power law explains the drug release from the polymeric 
system in which release deviates from Fickian diffusion, as 
expressed in following equation. 
Mt / M∞=ktn  
Log [Mt /  = M∞ ] logk + n log t 
Where Mt and M∞ are cumulative amounts of drug release at 
time t and infinite time (i.e. fraction of drug release at time 
t), 
k = constant incorporating structural and geometrical 
characteristics of CR device, 
n = diffusion release exponent indicative of the mechanism 
of release for drug Dissolution. 
To characterize the release mechanism, 
The dissolution data{ Mt / M∞ <0.6} versus log t will be linear 
with slope of n and intercept gives the value of log k. Antilog 
of log k gives the value of k 18. 
Table 2 Interpretation of diffusion release mechanisms 
   n Mechanism 
 0.45 Fickian diffusion 
0.45 < n < 0.89 Anomalous ( Non- Fickian) diffusion 
0.89 Case Ⅱ transport 
Above 0.89 Super case Ⅱ transport 
  
Effect of Formulation Variables on the Formation of 
Microsponges  
Effect of drug: polymer ratio  
In order to evaluate the effect of drug on the formation of 
microsponge, different Eudragit polymer to Fluconazole 
ratios (1:2, 1:4, 1:6, 1:8 and 1:10) were used to prepare 
microsponges. The formed microsponges were evaluated for 
their appearance, drug content, particle size and entrapment 
efficiency 19.  
Effect of stirring speed on the formation of 
microsponges  
In order to evaluate the effect of stirring speed on the 
formation of microsponges, were prepared with different 
RPM of 500, 800, 1000,1200 and 1500, the formed 
microsponges were evaluated for their drug content and 
particle size 20,21.     
RESULT AND DISCUSSION  
Standard curve of fluconazole and absorption maxima  
A precise, sensitive and accurate method for estimating 
fluconazole was developed using UV visible 
spectrophotometer.  
Preparation of standard stock solution 
Accurately weigh 100 mg fluconazole was taken in a clean 
And dry 100ml volumetric flask and was dissolved in 7.4 
phosphate buffer. Then 1 ml of above solution was taken and 
then dissolve in another 100ml of 7.4 phosphate buffer ( 
stock solution) than from the stock solution 1ml of solution 
was taken and dissolve in 100ml of 7.4 phosphate buffer to 
make 1μg/ml solution. After that 1,2,3,4,5,6,7,8,9,10μg/ml 
solutions were made by dissolving 1,2,3,4,5,6,7,8,9,10μg/ml 
solutions in 10 ml 7.4 phosphate buffer.  
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Procedure: From stock solution 1,2,3,4,5,6,7,8,9,10ml were 
withdrawn separately in different 10ml volumetric flasks 
and volume made in each case up-to 10ml of 7.4 phosphate 
buffer to produce the concentration 
1,2,3,4,5,6,7,8,9,10μg/ml. Absorbance of these solutions 
were recorded at λmax 260nm against (distilled water) blank 
using UV-visible spectrophotometer and standard curve was 
plotted between concentration v/s absorbance.  
DETERMINATION OF ABSORPTION MAXIMA (λmax)  
UV scan of fluconazole in phosphate buffer pH 7.4 was done. 
Analysis by UV spectrophotometer depicted absorption 
maxima of fluconazole at λmax was 260 nm at pH 7.4 of 
phosphate buffer.  
 
Fig. 1 Absorption spectra of Fluconazole 
 
 
Fig. 2 Absorption maxima of Fluconazole 
 
 CONSTRUCTION OF CALIBRATION CURVE  
Table 3 Calibration curve data for Fluconazole 
conc. (μg/ml) Absorbance 
1 0.008 
2 0.009 
3 0.01 
4 0.011 
5 0.014 
6 0.016 
7 0.019 
8 0.022 
9 0.024 
10 0.026 
 
 
 
STANDARD CURVE OF FLUCONAZOLE IN PHOSPHATE 
BUFFEER pH 7.4  
 
Fig. 3 Calibration curve of Fluconazole 
Evaluation of microsponges  
Production/Percentage yield (%) 
The production yields of fluconazole are shown in fig 4. 
Production yield calculated for all microsponges ranged 
from 44.17 to 78.24%. The readings are mean of three 
different measurements ±SD. It was found that production 
yield increases with increase in drug: polymer ratio.  
Table 4 Production yield of Fluconazole microsponges 
Formulation Code Percentage Yield 
F1 44.17 
F2 56.47 
F3 64.38 
F4 78.24 
F5 77.36 
 
 
Fig. 4 Production yield of Fluconazole microsponges 
Encapsulation efficiency/Loading efficiency (%) 
The loading efficiency of fluconazole microsponges 
formulations are shown in fig. 5. The loading efficiency 
calculated for all microsponges range from 33.17 to 82.76% 
- the highest loading efficiency. The was found for the 
formulation F4 where a greater amount of drug was 
encapsulated. It is indicated that fluconazole/ Eudragit L 100 
ratio (1:8) had the optimum capacity for drug entrapment.  
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Table 5 Encapsulation efficiency/ loading efficiency (%) 
of Fluconazole microsponges 
Formulation Codes Drug Loading Efficiency 
F1 33.17 
F2 53.74 
F3 69.94 
F4 82.76 
F5 80.38 
 
 
Fig. 5 Encapsulation efficiency of Fluconazole 
microsponges 
Size Analysis of Microsponge  
The average particle size of Fluconazole microsponge is 
ranges from 76.2 to 32.5. It was observed that as the ratio of 
drug to polymer increased, the particle size decreased. This 
could be due to the reason that in high drug to polymer ratio, 
the amount of polymer available per microsponge was 
comparatively less. In high drug: polymer ratio less polymer 
amount surround the drug and decreasing the thickness of 
polymer wall and microsponges with smaller size were 
obtained.   
Table 6 Average Particle Size of Microsponge 
Formulation Code Average Particle Size (μm) 
F1                    76.2 
F2                    64.4 
F3                    58.7 
F4                    32.5 
F5                    34.6 
 
Drug Content  
The drug content was determined by using phosphate buffer 
(pH 7.4) with the help of UV spectrophotometer by 
dissolving the formulation in phosphate buffer for 24 hours 
and then sample was taken and analyzed in UV- 
spectrophotometer. It was revealed that the formulation F4 
have the greater drug content. The drug content from F1-F5 
ranges between 37.44 to 81.36%.  
Table 7 Drug Content of Microsponges 
Formulation Code Drug Content (mean ±S.D) n=3 
             F1 37.44 
             F2 53.57 
             F3 69.35 
             F4 81.36 
             F5 80.24 
 
Scanning electron microscopy  
The SEM photographs of the microsponges are shown in fig. 
6. SEM images showed the microsponges are porous and 
spherical in shape. No intact drug crystal are seen visually 
and inner structure was porous with void spaces. The pores 
were induced by the diffusion of the solvent from the surface 
of the microsponges.  
 
 
Fig. 6 Images showing structure and porosity of microsponge 
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In-vitro dissolution studies 
It was observed as the concentration of Eudragit was 
increased, the percent release of fluconazole decreases. The 
increase in Eudragit concentration leads to the increased 
density of polymer matrix into the microsponges which 
result in an increased diffusional path length.  
 
 
Fig. 7 In-Vitro Drug Release of Fluconazole Microsponge 
Drug release kinetic of Fluconazole microsponges  
Zero order release kinetics  
 
Fig. 8 Zero order release kinetic of Fluconazole microcsponges 
First order release kinetics  
 
Fig. 9 First order release kinetic of Fluconazole microsponge 
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Higuchi release kinetics  
 
Fig. 10 Higuchi release kinetic of Fluconazole micro sponge 
Peppas release kinetics  
 
Fig. 11 Peppas release kinetic of fluconazole micro sponge 
 
The mechanism of drug release from the formulation during 
the dissolution was determined using the zero order, first 
order, higuchi equation and peppas equation. All formulation 
were best fitted to zero order and peppas plot. The best 
formulation F4 follows zero order kinetic. 
Effect of Formulation Variables on the Formation of 
Microsponges  
Effect of drug: polymer ratio  
Production yield, entrapment efficiency and drug content 
was analysed to be increase with increase in drug polymer 
ratio, the drug: polymer ratio has reverse effect on particle 
size, as drug: polymer ratio increase, particle size decreases. 
Effect of stirring rate on the morphology and yield of 
microsponges  
The effect of stirring rate on the morphology of 
microsponges. The formulation with higher drug to polymer 
ratio was chosen to investigate the effect of stirring rate on 
the morphology of microsponges. The stirring rate was 
varied in the range of 500 to 1500 rpm. The dispersion of the 
drug and polymer into the aqueous phase was examined to 
be dependent on the agitation speed. As the speed was 
increased the size of microsponges was reduced and the 
microsponges were found to be spherical and uniform. As 
increases in the drug: polymer ratio particle size was 
decreases, which could be correlated with the kinetics of 
microsponge formation in the presence of comparatively 
lower concentrations of the polymer. It was also noted that 
at higher stirring rate, the production yield was increased.  
Effect of polymer concentration  
As the polymer concentration increased, more amount of 
polymer surrounding the drug, thus increasing the thickness 
of the wall of the polymer matrix which lead to extended  
diffusion path and ultimately to lesser drug release or 
extended release.  
CONCLUSION  
The aim of present study was to make the microsponge of 
fluconazole so that the drug is able to release in a controlled 
and targeted manner. Fluconazole is formulated as 
microsponges by quasi-emulsion solvent diffusion method 
using polymer Eudragit L 100. Varied drug :polymer ratio 
and stirring rate reflected remarkable effect on the particle 
size, drug content and encapsulation efficiency. It was 
observed that as the drug to polymer ratio was increased, the 
particle size decreased. The mechanism of drug release from 
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the formulation F4 during the dissolution was determined 
using the zero order, first order, higuchi equation and peppas 
equation. All formulation were best fitted to zero order and 
peppas plot. The best formulation F4 follow zero order.  
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